AdipoPharma closed a Series A round (amount undisclosed) in Jan 2023. The company is based in Strasbourg, France. Investors in the round: Good Growth Capital, Newton Biocapital II. Data as of 7 Aug 2026.
Amount undisclosed or unconverted.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
